|
|||||
|
|
Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization |
|
| Authors: | Rebekah Rittberg Bonnie Leung Zamzam Al-Hashami Cheryl Ho |
| Affiliation: | 1.BC Cancer, Department of Medical Oncology, Vancouver, BC V5Z 4E6, Canada;2.CancerCare Manitoba, Section of Hematology/Oncology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB R3E 0V9, Canada;3.Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat P.O. Box 566 P.C 123, Oman |
| Abstract: | |
| Keywords: | SCLC small cell lung cancer lurbinectedin chemotherapy-free interval second line real world evidence |